Communities

Law Society Communities

Our communities help you develop in your professional life and make the most out of your Law Society

Find out more

Civil Litigation Section

Case commentary: Bailey v GlaxoSmithKline UK Ltd [2017] EWHC 3195 (QB)

Alison Kirby analyses this judgment in which the High Court has considered, for the first time, whether the Arkin cap - the principle that a funder’s potential liability for adverse costs will be limited to the amount of the funding provided - still fits.

PREMIUM CONTENT

In order to access this content, you must be a member of the Competition Section and logged in.

If you have not registered before, you must use the email associated with your section membership

Not a member?

helpline: 020 7320 5804

email: caadmin@lawsociety.org.uk